A Brief Case Management Intervention to Promote Personal Recovery and Prevent Psychiatric Involuntary Readmissions.
Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18-64
SponsorStéphane Morandi
About this trial
The goal of this randomized control trial is to assess the effectiveness of a Brief Case Management (BCM) intervention aimed at promoting personal recovery and reducing the negative effects of coercion among people involuntarily admitted to a psychiatric hospital.
The main questions it aims to answer are :
* Does the Brief Case Management intervention reduce the incidence of involuntary readmission18 months after the initial involuntary hospitalisation? * What impact does the Brief Case Management intervention have on patients' involuntary readmission 6 months after the initial involuntary hospitalisation, as well as on their personal recovery, perceived coercion, satisfaction with treatment, and on their exposure to other forms of formal and informal coercion?
Participants will be randomly assigned to either the control or the intervention group, accordingly they will be asked to take part in:
Control Group:
* Three evaluation sessions (baseline, 6 and 18 months follow-up);
Intervention Group :
* Three evaluation sessions (baseline, 6 and 18 months follow-up); * The 5 sessions of the brief case management intervention (6th session optional).
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
To have been involuntarily admitted by a medical doctor;
To be aged between 18 and 64 years;
To domiciled in the Greater Lausanne area;
Disqualifiers
Patients with an organic mental disorder (F0, ICD-10);
Patients with intellectual disability (F7, ICD-10);
Patients unable to provide written consent due to a lack of discernment;
Patients unable to speak French well enough to participate in the study without the help of an interpreter.
Trial design
Design model
Parallel
Treatments tested in this trial
Brief Case Management intervention
Other interventionThe BCM intervention aims to support patients during the difficult phase of involuntary hospitalisation and reduce the impact of this short-term event on their long-term recovery process. It is provided by a nurse or social worker case manager. Developed in collaboration with people who have experienced coercion, the intervention starts during the hospital stay, at the latest two weeks after admission, and lasts for a maximum of two months after discharge. The intervention consists of five sessions, the order of which may vary according to the specific needs of the patient: Session 1: Definition of "personal recovery" and impact of coercion on it Session 2 and 3: Elaboration of the Personal Recovery Plan (PRP) Session 4: Network meeting to discuss the PRP Session 5: Finalisation of the PRP For those who request it, an additional session can be arranged after three months to monitor progress and eventually adjust the recovery plan.
TAU
Other interventionStandard inpatient and outpatient psychiatric care.
Treatment groups
262 Participants
are divided into 2 treatment groupsGroup A: Control GroupActive comparator 1 intervention
Group B: Intervention GroupExperimental treatment 1 intervention
Trial outcomes
Primary outcomes
1
Number of involuntary readmission(s) (long-term)
The study's primary outcome will be the number of involuntary readmissions occurred at any hospital of the Canton of Vaud 18 months after study enrolment (T2). Data on involuntary readmissions will be extracted from the Register of Protection Measures (RMP) of the Canton of Vaud and the participants medical records.
Time frame
Assessed at 18-month follow-up (T2).Secondary outcomes
1
Number of involuntary readmission(s) (short-term)
To assess the intervention's shorter-term effect, the number and duration of any involuntary readmission occurred at any hospital of the Canton of Vaud at the 6-month follow-up (T1) will be measured as secondary outcome. Data on involuntary readmissions will be extracted from the Register of Protection Measures (RMP) of the Canton of Vaud and the participants medical records.
Time frame
Assessed at 6-month follow-up (T1).2
Recovery Assessment Scale (RAS)
The French version of the Recovery Assessment Scale is a 24-item, self-report, patient-oriented outcome inventory. The instrument provides a total score of personal recovery as well as sub-scores on five specific dimensions: personal confidence and hope, willingness to ask for help, goal and success orientation, reliance on others, no domination by symptoms. Developed through participatory action research and narrative analysis, this is to date the most wildly used tool to measure personal recovery. The RAS has shown satisfactory psychometric properties and sensitivity to change over time.
Time frame
3 time point assessment: at baseline (T0), 6-month follow-up (T1), 18-month follow-up (T2).3
Empowerment Scale
The Empowerment Scale is a 28-item self-report measure assessing personal empowerment as defined by mental health service-users. A total score as well as five specific sub-scores can be calculated: self-esteem; power and powerlessness; community activism and autonomy; optimism and control over the future; righteous anger. This scale has shown excellent reliability and validity.
Time frame
3 time point assessment: at baseline (T0), 6-month follow-up (T1) and 18-month follow-up (T2).4
Rosenberg Self-Esteem Scale (RSS)
The French version of the Rosenberg Self-Esteem Scale, a 10-item inventory measuring self-esteem. This self-report scale has shown satisfactory psychometric properties.
Time frame
3 time point assessment : at baseline (T0), 6-month follow-up (T1), 18-month follow-up (T2).Sponsors and contacts
Click on the lead sponsor to view all of their trials.
Stéphane Morandi
Lead sponsor
University of Lausanne Hospitals
Sponsor institution
University of Lausanne
Collaborator
Source ClinicalTrials.gov